PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dexpanthenol | 201-327-3 | 81-13-0 | - | - | 1 | - | 1 | - | - | - | - | Details |
| 5-tert-butyl-2,4,6-trinitro-m-xylene | 201-329-4 | 81-15-2 | - | - | - | - | 1 | - | 1 | 1 | - | Details |
| α,α,2,6-tetrachlorotoluene | 201-332-0 | 81-19-6 | - | - | - | - | 1 | - | - | - | - | Details |
| Cholic acid | 201-337-8 | 81-25-4 | - | - | 1 | - | - | - | - | - | - | Details |
| Perylene-3,4:9,10-tetracarboxydiimide | 201-344-6 | 81-33-4 | 1 | 1 | 1 | - | - | - | - | - | - | Details |
| 1-hydroxy-4-(p-toluidino)anthraquinone | 201-353-5 | 81-48-1 | - | - | 1 | - | 1 | - | - | - | - | Details |
| N-(4-amino-9,10-dihydro-3-methoxy-9,10-dioxo-1-anthryl)-4-methylbenzenesulphonamide | 201-369-2 | 81-68-5 | - | - | 1 | - | - | - | - | - | - | Details |
| 6,15-dihydroanthrazine-5,9,14,18-tetrone | 201-375-5 | 81-77-6 | - | - | 1 | - | - | - | - | - | - | Details |
| Warfarin | 201-377-6 | 81-81-2 | - | - | - | - | - | 1 | - | - | - | Details |
| 1,8-bis[(4-methylphenyl)amino]anthraquinone | 201-398-0 | 82-16-6 | - | - | 1 | - | 1 | - | - | - | - | Details |